This company listing is no longer active
CANN Overzicht aandelen
Through its subsidiaries, operates as a cannabinoid company in Canada and the United States.
Sneeuwvlok Score | |
---|---|
Waardering | 2/6 |
Toekomstige groei | 0/6 |
Prestaties in het verleden | 0/6 |
Financiële gezondheid | 5/6 |
Dividenden | 0/6 |
Heritage Cannabis Holdings Corp. Concurrenten
Prijsgeschiedenis en prestaties
Historische aandelenkoersen | |
---|---|
Huidige aandelenkoers | CA$0.005 |
52 Week Hoogtepunt | CA$0.02 |
52 Week Laag | CA$0.005 |
Bèta | 0.85 |
11 maand verandering | 0% |
3 maanden verandering | 0% |
1 Jaar Verandering | -50.00% |
33 jaar verandering | -94.74% |
5 jaar verandering | -98.96% |
Verandering sinds IPO | -98.33% |
Recent nieuws en updates
Positive Sentiment Still Eludes Heritage Cannabis Holdings Corp. (CSE:CANN) Following 50% Share Price Slump
Mar 27Positive Sentiment Still Eludes Heritage Cannabis Holdings Corp. (CSE:CANN) Following 33% Share Price Slump
Feb 11Investors Continue Waiting On Sidelines For Heritage Cannabis Holdings Corp. (CSE:CANN)
Dec 18Recent updates
Positive Sentiment Still Eludes Heritage Cannabis Holdings Corp. (CSE:CANN) Following 50% Share Price Slump
Mar 27Positive Sentiment Still Eludes Heritage Cannabis Holdings Corp. (CSE:CANN) Following 33% Share Price Slump
Feb 11Investors Continue Waiting On Sidelines For Heritage Cannabis Holdings Corp. (CSE:CANN)
Dec 18Heritage Cannabis Holdings (CSE:CANN) Has Debt But No Earnings; Should You Worry?
Sep 16Heritage Cannabis Holdings Corp. (CSE:CANN) Looks Inexpensive After Falling 33% But Perhaps Not Attractive Enough
Jul 22Is Heritage Cannabis Holdings (CSE:CANN) Using Too Much Debt?
Jun 15Heritage Cannabis Holdings (CSE:CANN) Is Carrying A Fair Bit Of Debt
Aug 11Is Heritage Cannabis Holdings (CSE:CANN) A Risky Investment?
Aug 24Can You Imagine How Elated Heritage Cannabis Holdings' (CSE:CANN) Shareholders Feel About Its 775% Share Price Gain?
Mar 03Is Heritage Cannabis Holdings (CSE:CANN) Weighed On By Its Debt Load?
Jan 07Rendement voor aandeelhouders
CANN | CA Pharmaceuticals | CA Markt | |
---|---|---|---|
7D | 0% | -4.7% | -1.5% |
1Y | -50.0% | 17.0% | 21.1% |
Rendement versus industrie: CANN underperformed the Canadian Pharmaceuticals industry which returned 15.9% over the past year.
Rendement versus markt: CANN underperformed the Canadian Market which returned 10.7% over the past year.
Prijsvolatiliteit
CANN volatility | |
---|---|
CANN Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 9.9% |
Market Average Movement | 8.3% |
10% most volatile stocks in CA Market | 17.5% |
10% least volatile stocks in CA Market | 2.9% |
Stabiele aandelenkoers: CANN's share price has been volatile over the past 3 months.
Volatiliteit in de loop van de tijd: Insufficient data to determine CANN's volatility change over the past year.
Over het bedrijf
Opgericht | Werknemers | CEO | Website |
---|---|---|---|
2007 | n/a | David Schwede | heritagecann.com |
Heritage Cannabis Holdings Corp. Samenvatting
CANN fundamentele statistieken | |
---|---|
Marktkapitalisatie | CA$5.08m |
Inkomsten(TTM) | -CA$20.10m |
Inkomsten(TTM) | CA$29.79m |
0.2x
P/S-verhouding-0.3x
Koers/WinstverhoudingIs CANN overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
CANN resultatenrekening (TTM) | |
---|---|
Inkomsten | CA$29.79m |
Kosten van inkomsten | CA$17.71m |
Brutowinst | CA$12.08m |
Overige uitgaven | CA$32.18m |
Inkomsten | -CA$20.10m |
Laatst gerapporteerde inkomsten
Oct 31, 2023
Volgende inkomensdatum
n.v.t.
Winst per aandeel (EPS) | -0.02 |
Brutomarge | 40.56% |
Nettowinstmarge | -67.45% |
Schuld/Eigen Vermogen Verhouding | 35.1% |
Hoe presteerde CANN op de lange termijn?
Bekijk historische prestaties en vergelijking